The U.S. poured $4.9 trillion into health care in 2023, equal to roughly 17.6% of GDP, federal data show. What jumps out from ...

Insperity trades at a depressed valuation after a 70% drawdown, despite having a net-cash balance sheet and historically ...

Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.